Interactions between cell death induced by statins and 7-ketocholesterol in rabbit aorta smooth muscle cells

W Martinet1, D M Schrijvers, J-P Timmermans

  • 1Division of Pharmacology, Department of Pharmaceutical Sciences, University of Antwerp, Wilrijk, Belgium.

Abstract

Insights

7-Ketocholesterol induces smooth muscle cell (SMC) death via autophagy, while statins induce apoptosis. Their combined effects on cell death are not additive, suggesting differing mechanisms in atherosclerotic settings.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • 7-Ketocholesterol, an oxysterol found in atherosclerotic lesions, is known to cause smooth muscle cell (SMC) death.
  • Statins are cardioprotective but can induce SMC apoptosis, raising questions about their combined effects with 7-ketocholesterol.

Purpose of the Study:

  • To investigate the additive effects of statins and 7-ketocholesterol on SMC death.
  • To elucidate the distinct mechanisms of cell death induced by 7-ketocholesterol and statins.

Main Methods:

  • Cultured rabbit aorta SMCs were treated with 7-ketocholesterol and various statins (fluvastatin, simvastatin, pravastatin).
  • Cell viability was assessed using neutral red uptake.
  • Caspase activation and microtubule-associated protein 1 light chain 3 (LC3) processing (an autophagy marker) were measured.

Main Results:

  • 7-Ketocholesterol induced SMC death primarily through autophagy (LC3 processing).
  • Lipophilic statins (fluvastatin, simvastatin) induced SMC apoptosis (caspase activation) without LC3 processing.
  • At high concentrations, 7-ketocholesterol and statins showed additive cell death, but at lower statin concentrations, cell death was not additive, potentially due to autophagy interfering with caspase activation.

Conclusions:

  • 7-Ketocholesterol and lipophilic statins induce SMC death via distinct pathways: autophagy and apoptosis, respectively.
  • The non-additive cell death at lower statin concentrations suggests complex interactions between these pathways.
  • Drug effects observed in normal SMCs may not accurately predict outcomes in the context of atherosclerosis.

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...